SuperworthLifeStance Health EPS LFST
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- $0.13
- Latest quarter, Q2 FY26
- $0.06
- Fiscal year 2025
- $0.02
LifeStance Health's earnings per share was $0.13 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.06.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.02 | n/a |
| FY2024 | −$0.16 | n/a |
| FY2023 | −$0.51 | n/a |
| FY2022 | −$0.61 | n/a |
| FY2021 | −$1.03 | n/a |
| FY2020 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.06 | n/a | $0.13 | |
| Q1 FY26 | $0.04 | n/a | $0.06 | |
| Q4 FY25 | $0.03 | n/a | $0.02 | |
| Q3 FY25 | $0.00 | n/a | −$0.03 | |
| Q2 FY25 | −$0.01 | n/a | −$0.05 | |
| Q1 FY25 | $0.00 | n/a | −$0.10 | |
| Q4 FY24 | −$0.02 | n/a | −$0.16 | |
| Q3 FY24 | −$0.02 | n/a | −$0.26 | |
| Q2 FY24 | −$0.06 | n/a | −$0.41 | |
| Q1 FY24 | −$0.06 | n/a | −$0.48 | |
| Q4 FY23 | −$0.12 | n/a | −$0.51 | |
| Q3 FY23 | −$0.17 | n/a | −$0.52 |
Against its peers
Companies in Medical - Care Facilities nearest LifeStance Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| LFSTLifeStance Health | $0.13 | |
| CONConcentra Group Holdings Parent | $1.54 | +29% a year |
| SHCSotera Health | $0.57 | +613% a year |
| OPCHOption Care Health | $1.33 | +6% a year |
| NHCNational Healthcare | $8.89 | +32% a year |
| CHEChemed | $19.92 | +2% a year |
| PACSPACS | $1.75 | +113% a year |
| AVAHAveanna Healthcare | $1.23 | +1267% a year |
| PRVAPrivia Health | $0.21 | +91% a year |
| ENSGEnsign | $6.38 | +16% a year |
| MDPediatrix Medical | $2.09 | +62% a year |
| Peer median | $1.65 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on LifeStance Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.